52 results
DEFM14A
ENZ
Enzo Biochem, Inc.
24 Apr 23
Proxy related to merger
4:01pm
targets or arrangements currently in place for 2023 (including bonus target, incentive compensation target, deferred compensation, and commissions
PREM14A
ENZ
Enzo Biochem, Inc.
12 Apr 23
Preliminary proxy related to merger
8:49pm
or other rate of base pay, if applicable, (vii) other compensation targets or arrangements currently in place for 2023 (including bonus target, incentive
8-K
EX-99.2
01msylcxd7
17 Dec 20
Regulation FD Disclosure
12:43pm
DEFA14A
6yvvla ee
31 Dec 19
Additional proxy soliciting materials
5:30pm
DEFC14A
29tqm
5 Dec 19
Proxy in contested solicitation
4:22pm
PREC14A
26k5vrpjw
20 Nov 19
Preliminary proxy with contested solicitation
5:26pm
8-K
EX-99.1
61fn6li3qodomy8
15 Oct 19
Enzo Biochem Reports Fiscal Fourth Quarter and Full Year Financial Results
4:43pm
8-K
EX-99.1
pmgbbs1xf30 qb9
5 Aug 19
Other Events
4:05pm
8-K
EX-99.1
7zdsj
13 May 19
Enzo Biochem Inc. Announces Issuance of United States Patent for Treatment of Liver Cancer Using Ozanimod
4:58pm